A diagram of how surrogate viruses expressing the SARS-CoV-2 spike protein can be used to measure the activity of neutralizing antibodies that target the spike protein and prevent the virus from entering cells.
Higher concentrations of a neutralizing antibody block the entry of a vesicular stomatitis virus expressing the SARS-CoV-2 spike protein into cells grown in the laboratory.